Pluristem Therapeutics, Inc. (PSTI) Social Stream



Pluristem Therapeutics, Inc. (PSTI): $1.00

0.03 (-2.91%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add PSTI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#103 of 395

in industry

PLURISTEM THERAPEUTICS INC (PSTI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering PLURISTEM THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 5 $12.5 $3 $8.7 $1 770%
2022-02-24 4 $12.5 $3 $8.7 $1 770%
2022-05-10 3 $9 $3 $6 $1 500%

The Trend in the Analyst Price Target


Over the past 25 months, PSTI's average price target has gone down $10.12.

PSTI reports an average of 246.58% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-01 6 12.5 4 9.080 3.28 176.83%
2021-11-10 5 12.5 3 8.700 2.93 196.93%
2022-02-24 4 9.0 3 6.000 1.67 259.28%
2022-02-24 3 10.0 3 7.333 1.67 339.1%
2022-02-24 3 12.5 3 8.700 1.67 420.96%

PSTI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 89 days, PSTI's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PSTI as an investment opportunity.

  • In the context of all US stocks, PLURISTEM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 473.25% of them.
  • PLURISTEM THERAPEUTICS INC's average analyst price target is higher than 31.15% of all US stocks.
  • In terms of how PLURISTEM THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -349.98% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, PLURISTEM THERAPEUTICS INC's number of analysts covering the stock is higher than 101.39% of them.

Stocks similar to PLURISTEM THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PMCB, PHGE, and MIRO.

What is the outlook for PSTI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!